• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲心脏手术风险评估系统(EuroSCORE)在中国心脏瓣膜手术患者中的验证。

Validation of the European system for cardiac operative risk evaluation (EuroSCORE) in Chinese heart valve surgery patients.

作者信息

Wang Chong, Yao Feng, Han Lin, Zhu Ji, Xu Zhi-yun

机构信息

Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.

出版信息

J Heart Valve Dis. 2010 Jan;19(1):21-7.

PMID:20329486
Abstract

BACKGROUND AND AIM OF THE STUDY

The study aim was to assess the performance of the European System for Cardiac Operative Risk Evaluation (EuroSCORE) model in Chinese patients undergoing heart valve surgery.

METHODS

Between January 2003 and December 2007, the data from a total of 1726 consecutive patients who underwent heart valve surgery at the authors' center were collected and scored according to the additive and logistic EuroSCORE models. The patients were allocated to three risk subgroups, and the entire cohort and each risk subgroup analyzed. Calibration of the EuroSCORE model was assessed by the Hosmer-Lemeshow (H-L) test. Discrimination was tested by calculating the area under the receiver operating characteristic (ROC) curve.

RESULTS

Completed data from all 1726 patients were analyzed. There were significant differences in the prevalence of risk factors between the study sample and European cardiac surgery populations. The observed mortality was 4.46% overall, compared to 3.51% (additive) and 2.85% (logistic). The additive EuroSCORE model showed good calibration in predicting in-hospital mortality (H-L; p = 0.204), but the logistic EuroSCORE model underpredicted observed mortality (H-L; p = 0.038) in the entire cohort. Both, the additive and logistic EuroSCORE models showed good calibration in predicting in-hospital mortality in the medium- and high-risk subgroups, but overpredicted observed mortality in the low-risk subgroup. The discriminative power of both models for the entire cohort was poor (areas under the ROC curve of 0.644 and 0.647 for the additive and logistic models, respectively).

CONCLUSION

The additive and logistic EuroSCORE models gave an imprecise prediction for individual operative risk in heart valve surgery patients at the authors' center; thus, use of the EuroSCORE models for risk evaluation at this center may be unsuitable in the future. It will be necessary to re-examine the performance of the EuroSCORE model for predicting operative mortality in heart valve surgery on a multicenter database in China.

摘要

研究背景与目的

本研究旨在评估欧洲心脏手术风险评估系统(EuroSCORE)模型在中国接受心脏瓣膜手术患者中的表现。

方法

2003年1月至2007年12月期间,收集了作者所在中心连续1726例接受心脏瓣膜手术患者的数据,并根据累加式和逻辑EuroSCORE模型进行评分。将患者分为三个风险亚组,并对整个队列和每个风险亚组进行分析。通过Hosmer-Lemeshow(H-L)检验评估EuroSCORE模型的校准情况。通过计算受试者工作特征(ROC)曲线下面积来测试辨别力。

结果

对全部1726例患者的完整数据进行了分析。研究样本与欧洲心脏手术人群的风险因素患病率存在显著差异。总体观察到的死亡率为4.46%,而累加式模型预测的死亡率为3.51%,逻辑模型预测的死亡率为2.85%。累加式EuroSCORE模型在预测住院死亡率方面显示出良好的校准(H-L;p = 0.204),但逻辑EuroSCORE模型在整个队列中对观察到的死亡率预测偏低(H-L;p = 0.038)。累加式和逻辑EuroSCORE模型在预测中、高风险亚组的住院死亡率方面均显示出良好的校准,但在低风险亚组中对观察到的死亡率预测偏高。两个模型对整个队列的辨别力均较差(累加式和逻辑模型的ROC曲线下面积分别为0.644和0.647)。

结论

累加式和逻辑EuroSCORE模型对作者所在中心心脏瓣膜手术患者的个体手术风险预测不准确;因此,未来在该中心使用EuroSCORE模型进行风险评估可能不合适。有必要在中国的多中心数据库上重新审视EuroSCORE模型在预测心脏瓣膜手术手术死亡率方面的表现。

相似文献

1
Validation of the European system for cardiac operative risk evaluation (EuroSCORE) in Chinese heart valve surgery patients.欧洲心脏手术风险评估系统(EuroSCORE)在中国心脏瓣膜手术患者中的验证。
J Heart Valve Dis. 2010 Jan;19(1):21-7.
2
Validation of the EuroSCORE model in Australia.欧洲心脏手术风险评估系统(EuroSCORE)模型在澳大利亚的验证。
Eur J Cardiothorac Surg. 2006 Apr;29(4):441-6; discussion 446. doi: 10.1016/j.ejcts.2005.12.046. Epub 2006 Feb 13.
3
The Chinese coronary artery bypass grafting registry study: how well does the EuroSCORE predict operative risk for Chinese population?中国冠状动脉旁路移植术注册研究:欧洲心脏手术风险评估系统(EuroSCORE)对中国人群手术风险的预测效果如何?
Eur J Cardiothorac Surg. 2009 Jan;35(1):54-8. doi: 10.1016/j.ejcts.2008.08.001. Epub 2008 Sep 7.
4
Is the European System for Cardiac Operative Risk Evaluation useful in Chinese patients undergoing heart valve surgery?欧洲心脏手术风险评估系统在中国行心脏瓣膜手术的患者中是否有用?
Chin Med J (Engl). 2012 Oct;125(20):3624-8.
5
Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results.感染性心内膜炎的术前风险分层。欧洲心脏手术风险评估系统(EuroSCORE)模型有效吗?初步结果。
Eur J Cardiothorac Surg. 2007 Aug;32(2):281-5. doi: 10.1016/j.ejcts.2007.04.010. Epub 2007 Jun 4.
6
EuroSCORE predicts short- and mid-term mortality in combined aortic valve replacement and coronary artery bypass patients.欧洲心脏手术风险评估系统(EuroSCORE)可预测主动脉瓣置换术与冠状动脉搭桥术联合手术患者的短期和中期死亡率。
J Card Surg. 2009 Nov-Dec;24(6):637-43. doi: 10.1111/j.1540-8191.2009.00906.x.
7
Validation of Euroscore model in an Australian patient population.欧洲心脏手术风险评估系统(Euroscore)模型在澳大利亚患者群体中的验证。
ANZ J Surg. 2005 Jul;75(7):508-12. doi: 10.1111/j.1445-2197.2005.03440.x.
8
Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program.20世纪90年代欧洲瓣膜手术后早期死亡的危险因素:欧洲心脏手术风险评估系统(EuroSCORE)试点项目的经验教训
J Heart Valve Dis. 2001 Sep;10(5):572-7; discussion 577-8.
9
Logistic versus additive EuroSCORE. A comparative assessment of the two models in an independent population sample.逻辑回归与相加性欧洲心脏手术风险评估系统(EuroSCORE)。在一个独立人群样本中对两种模型的比较评估。
Eur J Cardiothorac Surg. 2004 Dec;26(6):1134-40. doi: 10.1016/j.ejcts.2004.09.003.
10
A simple predictive model of prolonged intensive care unit stay after surgery for acquired heart valve disease.后天性心脏瓣膜病手术后重症监护病房延长住院时间的简易预测模型。
J Heart Valve Dis. 2007 Mar;16(2):109-15.

引用本文的文献

1
Protocol for the PORT study: short-term perioperative rehabilitation to improve outcomes in cardiac valvular surgery - a randomised control trial.PORT 研究方案:心脏瓣膜手术围手术期短期康复以改善结局——一项随机对照试验。
BMJ Open. 2023 Dec 21;13(12):e074837. doi: 10.1136/bmjopen-2023-074837.
2
Diagnostic accuracy of copeptin and NT-proBNP level in predicting mortality and postoperative prognosis in coronary surgery with respect to EuroSCORE risk.就欧洲心脏手术风险评估系统(EuroSCORE)风险而言, copeptin和N末端B型利钠肽原(NT-proBNP)水平在预测冠状动脉手术死亡率和术后预后方面的诊断准确性。
Kardiochir Torakochirurgia Pol. 2022 Dec;19(4):205-210. doi: 10.5114/kitp.2022.122090. Epub 2022 Dec 24.
3
Physical performance tests and in-hospital outcomes in elective open chest heart surgery.
择期开胸心脏手术的体能测试与院内结局
Int J Cardiol Heart Vasc. 2022 Dec 21;44:101164. doi: 10.1016/j.ijcha.2022.101164. eCollection 2023 Feb.
4
Modifying risks to improve outcome in cardiac surgery: An anesthesiologist's perspective.改善心脏手术结局的风险调整:麻醉医生的观点
Ann Card Anaesth. 2017 Apr-Jun;20(2):226-233. doi: 10.4103/aca.ACA_20_17.
5
Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis.中性粒细胞与淋巴细胞比值对重度钙化性主动脉瓣狭窄患者不良临床结局的预后价值
PLoS One. 2016 Aug 22;11(8):e0161530. doi: 10.1371/journal.pone.0161530. eCollection 2016.
6
Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial.远程缺血预处理对心脏手术高危患者的影响(远程IMPACT):一项随机对照试验。
CMAJ. 2016 Mar 15;188(5):329-336. doi: 10.1503/cmaj.150632. Epub 2015 Dec 14.